Automatic assessment of body composition in children with lymphoma: results of a [<sup>18</sup>F]FDG-PET/MR study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 39012528.
- Also identified by DOI 10.1007/s00330-024-10957-4 and PMC identifier 11631997.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
To use Dixon-MR images extracted from [<sup>18</sup>F]FDG-PET/MR scans to perform an automatic, volumetric segmentation and quantification of body composition in pediatric patients with lymphoma. Pediatric patients with lymphoma examined by [<sup>18</sup>F]FDG-PET/MR at diagnosis and restaging were included. At each time point, axial fat and water Dixon T1w images of the thighs were automatically segmented and muscle volume, subcutaneous, intramuscular, and intermuscular fat volume were quantified. The metabolic activity of the largest nodal lesion and of muscles and subcutaneous fat was recorded. The paired samples t-test and Spearman's correlation coefficient were applied to evaluate potential differences between the two time points and the relationship between metabolic and body composition metrics, respectively. By logistic regression analysis, the prognostic role of the investigated variables was assessed. The applied significance level was p < 0.05 for all analyses. Thirty-seven patients (mean age ± SD 14 ± 3-years-old; 20 females) matched the inclusion criteria. After chemotherapy (interval between the two PET/MR scans, 56-80 days; median 65 days), muscle volume significantly decreased (629 ± 259 cm<sup>3</sup> vs 567 ± 243 cm<sup>3</sup>, p < 0.001) while subcutaneous, intramuscular and intermuscular fat increased (476 ± 255 cm<sup>3</sup> vs 607 ± 254 cm<sup>3</sup>, p < 0.001; 63 ± 20 cm<sup>3</sup> vs 76 ± 26 cm<sup>3</sup>, p < 0.001; 58 ± 19 cm<sup>3</sup> vs 71 ± 23 cm<sup>3</sup>, p < 0.001); the metabolic activity of the main nodal lesion, muscles, and subcutaneous fat significantly decreased (p < 0.05, each). None of the examined variables acted as predictors of the response to treatment (p = 0.283). A strong correlation between BMI and subcutaneous fat volume at diagnosis (r = 0.675, p < 0.001) and restaging (r = 0.600, p < 0.001) emerged. The proposed method demonstrated that pediatric patients with lymphoma undergo muscle loss and an increase of subcutaneous fat during treatment. The proposed automatic and volumetric MR-based assessment of body composition in children with lymphoma can be used to monitor the effect of chemotherapy and may guide tailored exercise programs during chemotherapy. T1w Dixon images can be used for the automatic segmentation and quantification of body composition. Muscle and subcutaneous fat volume do not act as predictors of the response to treatment in children with lymphoma. Chemotherapy induces changes in body composition in children with lymphoma.
Medical subject headings
- Fluorodeoxyglucose F18
- Body Composition
- Lymphoma
- Magnetic Resonance Imaging
- Positron-Emission Tomography
- Radiopharmaceuticals